(PharmaNewsWire.Com, August 10, 2017 ) Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood supply to the brain. Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Heart attacks and strokes respectively account for the highest number of deaths due to cardiovascular diseases, globally. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes.
Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Heart attacks and strokes respectively account for the highest number of deaths due to cardiovascular diseases. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes. Stroke is one of the leading cause of long term disability, occurring at a higher rate in the old age population. Moreover, stroke leads to 1 out of every 20 deaths, costing around $34 billion to U.S. annually. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.
Latin America Acute Ischemic Stroke Diagnosis and Treatment Market: Drivers & Restraints Latin America Acute Ischemic Stroke Treatment and Diagnosis Market is driven by factors such as advancements in surgical procedures, growing incidence of acute ischemia stroke. Increasing geriatric population, growing awareness about minimally invasive surgical procedures and rising healthcare spending are some of the other major factors fuelling the market growth whereas high cost of surgical procedures and unnecessary usage of medicine for the treatment of ischemic stroke and are hindering the growth of the market.
Latin America Acute Ischemic Stroke Diagnosis and Treatment market: Segmentation By Diagnostic Type Computed Tomography Magnetic Resonance Imaging Ultrasound Cerebral angiography Nuclear Imaging
By Surgery Type Carotid Endarterectomy Angioplasty Endovascular Mechanical Thrombectomy
Latin America Acute Ischemic Stroke Diagnosis and Treatment: Overview Carotid Endarterectomy is the largest segment accounting for a share of approximately XX% and is expected to maintain its strong share owing to high success rate, short treatment duration and easy availability. North America is the largest market for Acute Ischemic Stroke Diagnosis and Treatment devices accounting for a share of approximately XX% in 2015 and is estimated to continue its strong hold of the market owing to favourable government initiatives, technological innovations and increasing demand for ischemic stroke products. Europe is the second largest market and is mainly fueled by a large population base of geriatrics.
Latin America Acute Ischemic Stroke Diagnosis and Treatment: Region-wise Outlook On the basis of geography Latin America Acute Ischemic Stroke Diagnosis and Treatment Market is analyzed under various regions namely Brazil, Argentina and Mexico. Within Latin America, Brazil is the largest market for Acute Ischemic Stroke Treatment and Diagnosis Market accounting for a share of approximately XX%.
Key Questions Answered What is the current and future Acute Ischemic Stroke Diagnosis and Treatment Market outlook in Latin America? What trends are affecting the Latin America market?
What is the competitive landscape and market share of major players in the Acute Ischemic Stroke Diagnosis and Treatment space in Latin America?
What are the key, high growth markets that Acute Ischemic Stroke Diagnosis and Treatment manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Acute Ischemic Stroke Diagnosis and Treatment currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Acute Ischemic Stroke Diagnosis and Treatment ?
What are the challenges and barriers that have hindered widespread adoption of Acute Ischemic Stroke Diagnosis and Treatment?
What are the key sustainability strategies adopted by market players ?
Latin America Acute Ischemic Stroke Diagnosis and Treatment: Key Players Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.
Reasons to buy Latin America Acute Ischemic Stroke Diagnosis and Treatment Report: Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
